Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of (1,3), (1,6)-Beta-D-glucan on Insulin Sensitivity and Inflammatory Markers of the Metabolic Syndrome

NCT00403689 is registered in ClinicalTrials.gov with German Institute of Human Nutrition as lead sponsor.

NCT NCT00403689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00403689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of (1,3), (1,6)-Beta-D-glucan on Insulin Sensitivity and Inflammatory Markers of the Metabolic Syndrome
Lead sponsor
German Institute of Human Nutrition
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2006
Completion date
March 31, 2008
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overweight